Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cohen & Steers (CNS) Shares Outstanding (Diluted Average) (2016 - 2026)

Cohen & Steers' Shares Outstanding (Diluted Average) history spans 17 years, with the latest figure at $51.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed 0.34% to $51.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $51.6 million, a 0.34% change, with the full-year FY2025 number at $51.5 million, up 1.15% from a year prior.
  • Shares Outstanding (Diluted Average) hit $51.6 million in Q1 2026 for Cohen & Steers, roughly flat from $51.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CNS hit a ceiling of $51.6 million in Q1 2026 and a floor of $49.3 million in Q2 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $50.3 million across 5 years, with a median of $49.8 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 0.11% in 2022 and later rose 3.91% in 2024.
  • Tracing CNS's Shares Outstanding (Diluted Average) over 5 years: stood at $49.3 million in 2022, then increased by 0.52% to $49.6 million in 2023, then rose by 2.79% to $50.9 million in 2024, then increased by 1.15% to $51.5 million in 2025, then increased by 0.13% to $51.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CNS at $51.6 million in Q1 2026, $51.5 million in Q4 2025, and $51.5 million in Q3 2025.